🇺🇸 FDA

Intelligence Platform

Patents

Browse 783 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9511075

Targeting NCCA-ATP channel for organ protection following ischemic episode

The United States of America as Represented by the Dept. of Veterans Affairs · Granted Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9506041

Delivery of packaged RNA to mammalian cells

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9498526

Human rotavirus vaccine strains and diagnostics

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9492564

Dual specific immunotoxin for brain tumor therapy

The United States of America as Represented by the Secretary of Health and Human Services, National Institutes of Health · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9486518

Membrane proximal region of HIV GP41 anchored to the lipid layer of a virus-like particle

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9474793

Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9458215

Compositions and methods for osteogenic gene therapy

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9458086

Compositions and methods for adipocyte modulation

The United States of America as Represented by the Department of Veterans Affairs Office of General Counsel—PSG IV (024) · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9439935

Recombinant rift valley fever (RVF) viruses and methods

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9435000

Primate T-lymphotropic viruses

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9421250

Pathogenic phlebovirus isolates and compositions and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9415099

Method of altering the immundominance hierarchy of HIV gag by DNA vaccine expressing conse

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9403872

Mutated anthrax toxin protective antigen proteins that specifically target cells containin

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9388221

Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing anti

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9387224

Treatment of specific cardiovascular conditions with nitrite

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9382302

Lutzomyia longipalpis polypeptides and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9375424

Compounds that treat malaria and prevent malaria transmission

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9375438

Inhibitors of NCCa-ATP channels for therapy

The United States of America as Represented by the Dept. of Veterans Affairs · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9365626

Simukunin

The United States of America as represented by the Secretary of the Dept. of Health & Human Services · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9358306

Photosensitizing antibody-fluorophore conjugates

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9353117

Substituted pyrazolopyrimidines as glucocerebrosidase activators

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9345758

Materials and methods for respiratory disease control in canines

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9346875

Therapy for filovirus infection

The United States of America as represented by the Secretary of the Army · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9347951

Fusion protein comprising the extracellular domain of a filovirus glycoprotein fused to an

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted